1 |
B. S. Chung and M, G, Shin, Dictionary of Korean Folk Medicine, Yong Lim Sa, p. 458 (1990).
|
2 |
U. Y. Yu, S. Y. Kang, H. Y. Park, S. H. Sung, E. J. Lee, S. Y. Kim, and Y. C. Kim, Antioxidant lignans from Machilus thunbergii protect CCl4-injured primary cultures of rat hepatocytes, J. Pharm. Pharmacol., 52, 1163 (2000).
DOI
|
3 |
H. Shimomura, Y. Sashida, and M. Oohara, Lignans from Machilus thunbergii, Phytochemistry, 26, 1513 (1987).
DOI
|
4 |
H. Karikome, Y. Mimaki, and Y. Sashida, A butanolide and phenolics from Machilus thunbergii, Phytochemistry, 30, 315 (1991).
DOI
|
5 |
C. J. Ma, S. H. Sung, and Y. C. Kim, Neuroprotective lignans from the bark of Machilus thunbergii, Planta Med., 70, 79 (2004).
DOI
|
6 |
M. K. Lee, H. Yang, C. J. Ma, and Y. C. Kim, Stimulatory activity of lignans from Machilus thunbergii on osteoblast differenctiation, Biol. Pharm. Bull., 30, 814 (2007).
DOI
|
7 |
H. I. Moo and J. H. Chung, Meso-dihydroguaiaretic acid from Machilus thunbergii SIEB et Zucc., and its effects on the expression of matrix metalloproteinase- 2, 9 cause by ultraviolet irradiated cultured human keratinocyte cells (HaCaT), Biol. Pharm. Bull., 28, 2176 (2005).
DOI
|
8 |
H. Y. Park, H. S. Rho, D. H. Kim, H. G. D. H. Kim, Q. Q. He, and J. H. Yeon, Modified rancimat method for evaluation of antioxidative effect against skin lipid, Bull. Korean Chem. Soc., 31, 1751 (2010).
DOI
|
9 |
G. Li, H. K. Ju, H. W. Chang, Y. Jahng, S. H. Lee, and J. K. Son, Melanin biosynthesis inhibitors from the bark of Machilus thunbergii, Biol. Pharm. Bull., 26, 1039 (2003).
DOI
|
10 |
J. H. Ryu, H. Ahn, J. Y. Kim, and Y. K. Kim, Inhibitory activity of plant extracts on nitric oxide synthesis in LPS-activated macrophages, Phytother. Res., 17, 485 (2003).
DOI
|
11 |
J. R. Kanwar, R. K. Kanwar, H. Burrow, and S. Baratchi, Recent advances on the roles of NO in cancer and chronic inflammatory disorders, Curr. Med. Chem., 19, 2373 (2009).
|
12 |
J. Park, J. H. Park, H. J. Suh, I. C. Lee, J. Koh, and Y. C. Boo, Effects of resveratrol, oxyresveratrol, and their acetylated derivatives on cellular melanogenesis, Arch. Dermatol., 306, 475 (2014).
DOI
|
13 |
D. S. Bredt, Endogenous nitric oxide synthesis: biological functions and phathophysiology, Free. Radic. Res., 31, 577 (1999).
DOI
|
14 |
T. J. Guzik, R. Korbut, and T. Adamek-Guzik, Nitric oxide and superoxide in inflammation and immune regulation, J. Physiol. Pharmacol., 54, 469 (2003).
|
15 |
H. S. Rho, H. S. Baek, J. W. Yoo, S. J. Kim, M. K. Kim, D. H. Kim, and I. S. Chang, Biological activities of 3,5-dihydroxy-N-(4-hydroxyphenyl)benzamide : A mimic compound of trans-resveratrol, Bull. Korean Chem. Soc., 28, 837 (2007).
DOI
|
16 |
H. Yoo, S. H. Kim, J. Lee, H. J. Kim, S. H. Seo, B. Y. Chung, C. Jin, and Y. S. Lee, Synthesis and antioxidants activity of 3-methoxyflavones,. Bull. Korean Chem. Soc., 26, 2057 (2005).
DOI
|
17 |
Z. H. Shi, N. G. Li, Y. P. Tang, J. P. Yang, and J. A. Duan, Metabolism-based synthesis, biological evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors, Eur. J. Med. Chem., 54, 210 (2012).
DOI
|
18 |
K, Koide, S. Osman, A. L. Garner, F. Song, T. Dixon, J. S. Greenberger, and M. W. Epperly, The use of 3,5,4'-tri-O-acetylresveratrol as a potent pro-drug for resveratrol protects mice from g-irradiation- induced death, ACS Med. Chem. Lett., 2, 270 (2011).
DOI
|
19 |
L. Ma, Y. Zhao, B. Li, Q. Wang, X. Liu, X. Chen, Y. Nan, L. Liang, R. Chang, L. Liang, P. Li, and F. Jin, 3,5,4'-tri-O-acetylresveratrol attenuates seawater aspiration-induced lung injury by inhibiting activation of nuclearfactor-kappa B and hypoxia-inducible factor- 1a, Respir. Physiol. Neurobiol., 185, 608 (2013).
DOI
|